Nanovalent Pharmaceuticals Inc.
Bozeman, MT
- UEI
- NFPTYA1R6KY1
- CAGE
- 4LGY2
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 351 Evergreen Dr Ste B, Bozeman, MT 59715, USA
- Website
- nanovalentpharma.com
- Founded
- 2006
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Quick answers
Is Nanovalent Pharmaceuticals Inc. registered in SAM.gov?
Yes. Nanovalent Pharmaceuticals Inc.'s SAM.gov registration is active through January 6, 2027.
What is Nanovalent Pharmaceuticals Inc.'s most recent federal award?
Nanovalent Pharmaceuticals Inc.'s most recent federal grant award is Tumor antigen targeted nanoparticle therapy for glioblastoma (GBM) (R42CA281707), from National Cancer Institute (NIH), on August 8, 2023.
On GovTribe
See Nanovalent Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors